87 related articles for article (PubMed ID: 2564267)
41. Effects of inhaled sympathomimetics on obstructive response to respiratory heat loss.
Rossing TH; Weiss JW; Breslin FJ; Ingram RH; McFadden ER
J Appl Physiol Respir Environ Exerc Physiol; 1982 May; 52(5):1119-23. PubMed ID: 7047469
[TBL] [Abstract][Full Text] [Related]
42. Workshop Proceedings on Bronchoprovocation Techniques for the Evaluation of Asthma, October 14--15, 1978, Atlanta, Georgia. The Bronchoprovocation Committee, American Academy of Allergy.
J Allergy Clin Immunol; 1979 Dec; 64(6 pt 2):561-692. PubMed ID: 41865
[No Abstract] [Full Text] [Related]
43. Statistical considerations in studies of exercise-induced bronchospasm.
Johnson JD
J Allergy Clin Immunol; 1979 Dec; 64(6 pt 2):634-41. PubMed ID: 389991
[No Abstract] [Full Text] [Related]
44. [Clinical manifestations, diagnosis and treatment of exercise induced asthma].
Liebhart J; Dor A; Małolepszy J
Pneumonol Alergol Pol; 1996; 64(7-8):481-8. PubMed ID: 8983452
[No Abstract] [Full Text] [Related]
45. Comparison of real and placebo acupuncture in histamine-induced asthma. A double-blind crossover study.
Tandon MK; Soh PF
Chest; 1989 Jul; 96(1):102-5. PubMed ID: 2736966
[TBL] [Abstract][Full Text] [Related]
46. Exercise-induced bronchoconstriction in patients with bronchial asthma. Its prevention with an antihistaminic agent.
Zieliński J; Chodosowska E
Respiration; 1977; 34(1):31-5. PubMed ID: 16323
[TBL] [Abstract][Full Text] [Related]
47. Initial nociceptive sensitization in carrageenin-induced rat paw inflammation is dependent on amine autacoid mechanisms: electrophysiological and behavioural evidence obtained with a quaternary antihistamine, thiazinamium.
Neil A; Benoist JM; Kayser V; Guilbaud G
Exp Brain Res; 1987; 65(2):343-51. PubMed ID: 2881800
[TBL] [Abstract][Full Text] [Related]
48. Exercise-induced asthma.
Bierman CW
N Engl Reg Allergy Proc; 1988; 9(3):193-7. PubMed ID: 3045522
[TBL] [Abstract][Full Text] [Related]
49. Exercise-induced bronchoconstriction: A survey of diagnostic practice in secondary care across the United Kingdom.
Simpson AJ; Drake SM; Fowler SJ
Allergy; 2020 Aug; 75(8):2130-2132. PubMed ID: 32249953
[No Abstract] [Full Text] [Related]
50. The protective effect of lodoxamide on antigen-induced bronchospasm. An orally active antiallergic drug.
Case RL; Rogers PB; VanArsdel PP; Altman LC
JAMA; 1982 Feb; 247(5):661-4. PubMed ID: 7033581
[No Abstract] [Full Text] [Related]
51. Exercise-Induced Bronchoconstriction.
MacCallum DS; Comeau D
Curr Sports Med Rep; 2016; 15(3):128-9. PubMed ID: 27172072
[No Abstract] [Full Text] [Related]
52. Improvement of "irreversible" airway obstruction by thiazinamium (Multergan).
Bouhuys A; Ortega J
Pneumonologie; 1976 Jun; 153(3):185-95. PubMed ID: 785411
[No Abstract] [Full Text] [Related]
53. The effect of zaprinast (M&B 22,948, an orally absorbed mast cell stabilizer) on exercise-induced asthma in children.
Reiser J; Yeang Y; Warner JO
Br J Dis Chest; 1986 Apr; 80(2):157-63. PubMed ID: 3524648
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patients.
Holford NH; Clements P; Collier P; Orie NG; van Bork LE; Jonkman JH
Eur J Clin Pharmacol; 1987; 33(3):237-42. PubMed ID: 2891535
[TBL] [Abstract][Full Text] [Related]
55. Clinical studies with calcium antagonists in asthma.
Barnes PJ
Br J Clin Pharmacol; 1985; 20 Suppl 2(Suppl 2):289S-298S. PubMed ID: 3902071
[No Abstract] [Full Text] [Related]
56. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.
Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG; Soeterboek AM; Bender J
Pharm Weekbl Sci; 1982 Oct; 4(5):122-8. PubMed ID: 6128713
[TBL] [Abstract][Full Text] [Related]
57. Criteria for the clinical evaluation of prophylactic agents in bronchial asthma.
Craps L
Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():272-8. PubMed ID: 7309262
[TBL] [Abstract][Full Text] [Related]
58. "First pass effect" after rectal administration of thiazinamium methylsulphate [proceedings].
Jonkman JH; van Bork LE; Wijsbeek J; de Zeeuw RA; Orie NG; Cox HL
J Pharm Pharmacol; 1976 Dec; 28 Suppl():56P. PubMed ID: 12333
[No Abstract] [Full Text] [Related]
59. First-pass effect after rectal administration of thiazinamium methylsulfate.
Jonkman JH; van Bork LE; Wijsbeek J; Bolhuis-de Vries AS; de Zeeuw RA; Orie NG; Cox HL
J Pharm Sci; 1979 Jan; 68(1):69-72. PubMed ID: 758468
[TBL] [Abstract][Full Text] [Related]
60. Variations in the bioavailability of thiazinamium methylsulfate.
Jonkman JH; Van Bork LE; Wijsbeek J; De Zeeuw RK; Orie NG
Clin Pharmacol Ther; 1977 Apr; 21(4):457-63. PubMed ID: 849677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
